Allstate Corp Rocket Pharmaceuticals, Inc. Transaction History

Allstate Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$13.16 - $23.68 $122,230 - $219,939	-9,288 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$21.52 - $36.02 $5,659 - $9,473	-263 Reduced 2.75%	9,288 $203,000
Q3 2021 Nov 15, 2021	BUY	$27.42 - $48.97 $96,710 - $172,717	3,527 Added 58.55%	9,551 $285,000
Q1 2021 May 14, 2021	BUY	$43.34 - $65.91 $261,080 - $397,041	6,024 New	6,024 $267,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $875M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.